The psychotherapeutic action of Li' in brain has been proposed to result from the depletion of cellular inosito1 secondary to its block of inositol monophosphatase. This action is thought to slow phosphoinositide resynthesis, thereby attenuating stimulated phosphoinositidase-mediated signal transduction in affected cells. In the present study, the effect of Lit on muscarinic receptor-stimulated formation of the immediate precursor of phosphatidylinositol, CDP-diacylglycerol (CDP-DAG), has been examined in 2 mM) . The present study thus demonstrates, in the same cultured cell line, the effects of normal and reduced intracellular inositol levels on the ability of Li' to attenuate phosphoinositide resynthesis, as inferred from [3H]CDP-DAG accumulation. The results indicate that Li' can lead to a slowing of stimulated phosphoinositide turnover in neuroblastoma cells, provided that the intracellular inositol content has been significantly reduced.
4 nmol/mg of protein, a level comparable with that seen in cortical slices. In these inositol-depleted cells, Li' potentiated carbachol-stimulated [3H]CDP-DAG formation, and this effect was completely reversed by coincubation with inositol (ECS0 0.2 mM). The present study thus demonstrates, in the same cultured cell line, the effects of normal and reduced intracellular inositol levels on the ability of Li' to attenuate phosphoinositide resynthesis, as inferred from [3H]CDP-DAG accumulation. The results indicate that Li' can lead to a slowing of stimulated phosphoinositide turnover in neuroblastoma cells, provided that the intracellular inositol content has been significantly reduced. Key Words:
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Lithium (Li+) is widely used in the treatment of manic-depressive disorders, although the molecular basis of its therapeutic action remains unclear. The possibility of a postreceptor site of action was suggested from earlier studies reporting an inhibition of stimulated adenylate cyclase activity by Lif in several tissues, including brain (Forn and Valdecasas, 197 1 ; Ebstein et al., 1980) . Attenuation of the phosphoinositidase-mediated signal transduction pathway by Lit, a potent uncompetitive inhibitor of inositol monophosphatase (Hallcher and Sherman, 1980) , was suggested by a number of studies (Allison and Stewart, 1971; Allison et a].., 1976; Sherman et al., 1981 Sherman et al., , 1985 that demonstrated a large accumulation of inositol monophosphates concomitant with a reduction in inositol content after CNS receptor activation. That inhibition of inositol monophosphatase by Li+ may result in the depletion of intracellular inositol content, and thereby interrupt the resynthesis of phosphoinositides (Sherman et al., 1981; Berridge et al., 1982) , is particularly relevant to the CNS because inositol cannot be readily replenished from the periphery due to the selective permeability of the blood-brain barrier. Recent studies using cerebral cortex slices have demonstrated inhibitory effects of Li+ on muscarink stimulated inositol tris-and tetrakisphosphate accumulation (Whitworth and Kendall, 1988; Kennedy et al., 1989 Kennedy et al., , 1990 , an effect that is shown in some cases to be reduced by coincubation with inositol. However, the inability of Li+ to reduce levels of phosphatidylinositol 4,5 -bisphosphate (PIP, ) in treated tissue (Drummond and Raeburn, 1984; Downes and Stone, 1986; Honchar et al., 1989) complicates the inositol depletion model. A multiplicity of the effects of Li+ on several enzymes of the inositol phosphate cycle (Inhorn and Majerus, 1987; Gee et al., 1988) and alternate mechanisms including other postreceptor sites (Wood and Goodwin, 1987; Godfrey et al., 1989; Avissar et al., 1988 Avissar et al., , 1991 are now recognized.
More direct evidence for an effect of Li' on the phosphoinositidase-mediated second messenger system has been obtained by measuring agonist-induced formation of CDP-diacylglycerol (CDP-DAG), the immediate precursor of phosphatidylinositol (PI), in brain slices (Godfrey, 1989; Kennedy et al., 1990) . Although this effect by Li' on CDP-DAG accumulation has also been observed in parotid gland slices (Downes and Stone, 1986) , human platelets (Watson et al., 1990) , and human neutrophils , it could not be demonstrated in cultured cells (Drummond and Raeburn, 1984) . The response to Li+ in these various cell preparations might be explained on the basis of differences in endogenous inositol levels. The present study was therefore undertaken to examine the effect of Lif on muscarinic agonist stimulation of CDP-DAG in cultured human SK-N-SH neuroblastoma cells grown under conditions that modulate intracellular inositol content. A preliminary report of this study has appeared in abstract form (Stubbs et al., 1991) .
MATERIALS AND METHODS
Human SK-N-SH neuroblastoma cells of the neuroblast phenotype were cultured at 37°C in a humidified atmosphere (10% C0,/90% air) in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (GIBCO BRL, Grand Island, NY, U.S.A.). Where specified, SK-N-SH cells were cultured in an inositol-free chemically defined (IFCD) growth medium (Bottenstein and Sato, 1979) , which was changed daily for 5-7 days for the purpose of depleting cellular inositol. Adolescent (1 3-18 days) rats were killed by decapitation and the cerebral cortex was dissected, cross-chopped with a Mcllwain tissue chopper (350 X 350 pm), and slices were washed as described previously (Heacock et al., 1987) . SK-N-SH cells grown to confluency (7-10 days) were harvested with Puck's D, solution, washed once with buffer A containing (M) NaCl 142, KC1 5.4, NaHCO, 3.6, CaCI, 2.2, MgCI, 1.0, Dglucose 5.6, and HEPES 30, pH 7.4, saturated with OJCO, (19:1, vol/vol) , and suspended at a concentration of 1-2 mg of protein/ml. Gravity-packed slices (50 pl) or suspended cells (-0.3 mg of protein), in a final volume of 500 pl, were incubated in flat-bottomed polypropylene minivials in the presence of
[3H]cytidine (specific activity 25 Ci/mmol, 3 pCi per minivial; Sigma Chemical Co., St. Louis, MO, U.S.A.) for 60 rnin at 37°C followed by stimulation with either buffer A or a muscarinic agonist for 30-60 min. Reactions were quenched by the addition of 1.5 ml of chloroform/methanol (1:2, vol/vol), and labeled lipids were extracted from the lower phase formed upon the addition of 0.5 ml of HCl(l.2 M ) and 1.0 ml of chloroform. After phase separation by low-speed centrifugation, a portion of the resultant lower phase was washed twice with acidified methanol containing 2.5 mMcytidine (Sigma) and [3H]CDP-DAG was identified by TLC on oxalate-impregnated silica gel 60 plates developed in chloroform/acetone/methanol/acetic acid/water (40: 15: 13: 1223, by vol). The radiolabeled band comigrating with authentic CDP-DAG standard (see Fig. I ) was scraped and counted. Alternatively, a fraction of the acid-washed organic phase was dried and counted by scintillation spectrometry.
Cellular inositol was quantitated by a modification of the acetylation method of Mount and Laker (198 1) . In brief, prepared cells or cortical slices (-1 mg of protein each) were suspended in a total volume of 1 ml with distilled water in the presence of 50 pg of xylitol internal standard (Sigma). Cells or tissue slices were disrupted with 1.5 ml of chloroform/methanol (12, vol/vol) and were vortexed vigorously, followed by the addition of I .O ml of chloroform.
After phase separation by low-speed centrifugation, the upper aqueous phase was dried overnight in vacuo and then stored for at least 1 h over phosphorus pentoxide. Samples were acetylated by incubating at 70°C for 30 rnin in 0.5 ml of pyridine (previously refluxed for 30 rnin over potassium hydroxide and redistilled) followed by the addition of0.5 ml of acetic anhydride for an additional 10 rnin at 70°C. Acetylated samples were dried and stored as described above before separation on an SP2330 capillary column (Supelco, Bellefonte, PA, U.S.A.) using a Hewlett Packard 5890A gas chromatograph programmed with an isothermal oven temperature at 200°C for the first 2 rnin followed by a linear ramp up to 250"C, rising at a rate of 4"C/min, and sustained for an additional I4 min. Peaks were quantitated with a Hewlett Packard 3396A integrator. Under these conditions, acetylated inositol chromatographed free of glucose anomers and eluted as a single peak with a retention time of 23.5 min.
RESULTS

Muscarinic receptor-stimulated formation of rH]-CDP-DAG
The addition of carbachol (10 miM = 0.43). A qualitatively similar autoradiographic profile was observed when [3H]cytidine-prelabeled cortical slices were stimulated with 1 mM carbachol (data not shown). As has been previously observed, carbachol or Li+ alone had no effect on CDP-DAG accumulation, whereas the combination produced pronounced enhancement (Godfrey, 1989) . In contrast to results from experiments with cortical slices, the stimulated formation of [3H]CDP-DAG in cultured cells was independent of Li+ and was found to be insensitive to the presence of inositol (Table 1) . This stimulated production of [ 3H]CDP-DAG in SK-N-SH cells was time and concentration dependent.
There was a fivefold increase in [3H]CDP-DAG accumulation, which reached asymptote within 10 rnin of carbachol addition and was sustained for at least 30 min ( Fig. 2) . In parallel incubations, the addition of 10 pM atropine to carbachol-stimulated cells caused a rapid depletion of [3H]CDP-DAG, suggesting metabolism of newly synthesized CDP-DAG subsequent to muscarinic receptor blockade. The Lit-independent formation of [3H]CDP-DAG was observed at carbachol concentrations as low as 1 pMand was maximal at 1 m M with a half-maximal accumulation at 7.5 k 0.5 p M (Fig. 3) . The selectivity of muscarinic agonists in stimulating [3H]CDP-DAG formation agreed well with the known efficacy of these agents in initiating phosphoinositide turnover in SK-N-SH cells (Fisher and Snider, 1987) . In three separate experiments, the full muscarinic agonist oxotremorine-M ( 1 mM) was as effective at eliciting [3H]CDP-DAG formation (90 f 6%) as 1 mM carbachol, whereas equimolar concentrations of partial muscarinic agonists were less effective; thus, bethanechol(74
Intracellular inositol content
The inositol content of freshly cut cortical slices of adolescent rat brain was found to be 21 k 0.9 nmol/ mg of protein (n = 6), the same as is found in cortical samples taken directly from the brain shortly after decapitation (2 1.1 f 1.7 nmol/mg of protein; n = 3). After the washing procedure, the inositol content of the slices was reduced to 8.9 f 0.4 nmol/mg of protein (n = 6, p < 0.001), or -0.9 mM, well below the reported K, (4.6 mMinosito1) for rat brain PI synthase (Ghalayini and Eichberg, 1985) . This 60% reduction in cellular inositol content may thus slow PI synthase on the basis of substrate limitation, resulting in the accumulation of lipid precursors of the phosphoinositide cycle such as DAG, DAG-phosphate (phosphatidate), and/or CDP-DAG. In contrast to cortical slices, the inositol content in washed SK-N-SH cells was found to be 60.0 +. 4.0 nmol/mg of protein (n = 8).
This more closely approximates the value we found in the adult rat cortex, 48.5 f 1.5 nmol/mg of protein (n = 6 ) , a notably higher value than we observed in adolescent rat brain. These data suggest that the stimulated formation of [3H]CDP-DAG in SK-N-SH cells cultured in standard growth medium does not result from a deficit of cellular inositol, in contrast to what may well be the case in studies with prewashed cortical brain slices incubated in the presence of Li+ (Godfrey, 1989; Kennedy et al., 1990 ; Table 1 ). [3H]Cytidine-prelabeled cells (0.3-0.35 mg of protein) or 13-1 8-day-old-rat cortical slices ( 1 mg of protein) were treated with buffer (control) and 10 mM LiCl with or without 10 mM inositol as indicated, followed by incubation with carbachol for an additional 30 rnin (cells) or 60 rnin (slices). Data shown (dpm) are the means k SEM for separate SK-N-SH cell (n = 3) and cortical slice (n = 5 ) preparations. Control values for cortical slices are the average of duplicates. (Fig. 5) , suggesting that under these conditions, the accumulation of CDP-DAG resulted from inositol-substrate limitation of PI synthase and that therapeutic concentrations of Li+ further exacerbated this limitation. This effect by Lit on [3H]CDP-DAG formation was maximally effective at 10 mM with an EC,, of 2.6 f 0.3 mM (Fig. 6) . At concentrations as low as 50 pM, inositol reduced this potentiation by Li+, was maximal at 10 mM, and exhibited a halfmaximal effect at 0.20 * 0.03 mM (Fig. 7) .
To further investigate the nature of the atropine effect on [3H]CDP-DAG accumulation, the experiment described in Fig. 2 was repeated in inositol-depleted cells. Under these conditions, a linear accumulation of [3H]CDP-DAG was seen after addition of carbachol for 15 min, which then increased at later times. Atropine addition again resulted in a loss of labeled liponucleotide (Fig. 8) .
DISCUSSION
It has been amply demonstrated that after preincubation with [3H]inositol, the addition of an appropriate ligand such as carbachol in the presence of Li+ to a tissue slice or cultured cell incubation medium results in a pronounced accumulation oflabeled inosito1 phosphates (see Fisher et al., 1992) . Although it is evident that this accumulation is attributable to the uncompetitive inhibition of inositol monophosphatase by Li+ (Hallcher and Sherman, 1980) , it is less clear that this action of Li+ can also explain its wellknown beneficial actions in the treatment of psychoses. The inositol depletion hypothesis for the psychotherapeutic action of Li+ proposes that the block of inositol monophosphatase creates a shortage of inositol as substrate for the regeneration of phosphoinositides via PI synthase, and that this effect of Li+ is especially profound in those cells that have been most heavily stimulated (Bemdge et al., 1982) . Reversal by inositol of a Li+-mediated decrease of inositol polyphosphates in tissue slices (Whitworth and Kendall, 1988; Kennedy et al., 1989 Kennedy et al., , 1990 the hypothesis. Further support comes from recent in vivo evidence (Sun et al., 1992) that Li+ increases inositol phosphates, based on chemical mass determinations and labeled inositol incorporation. On the other hand, Whitworth et al. (1990) suggested that both chronic and acute Li+ treatment in vivo may actually enhance stimulated phosphoinositide turnover in brain. Sillence and Downes ( 1992) recently reported that both chemical amounts and labeling of the inosito1 phosphates were increased in Li+-treated tissue slices, but that increases seen in inositol phosphate mass were much less than labeling might otherwise indicate.
A major concern regarding the relevance of the inositol depletion hypothesis for the nervous system is the high content of inositol in the brain, and the relatively small decreases that are produced by chronic, or even by high acute doses of Lif in experimental ani- mals. Proponents of the inositol depletion hypothesis must then further postulate either that inositol has become depleted in an unmeasured, but behaviorally relevant, brain compartment (for example in neurons), or alternatively that there exists a PI synthase isozyme that has a higher K, for inositol than has thus far been demonstrated, but this has not as yet been found (Imai and Gershengorn, 1987) . The experimental approach used in the present study is based on the assumption that a slowing of the phosphoinositide cycle secondary to inositol depletion will result in an accumulation of CDP-DAG, the cosubstrate, with inositol, for PI synthase. Li+ produced no demonstrable effect on stimulated [3H]-CDP-DAG accumulation in SK-N-SH cells grown in standard culture media. Drummond and Raeburn ( 1984) had similarly reported an insensitivity of cultured GH, pituitary cells to Li+ in regard to ligandstimulated accumulation of labeled CDP-DAG. When we reduced cellular inositol levels in the neuroblastoma cells to the range of that seen in washed brain slices, the cultured cells now showed an inositolsensitive, Li+-stimulated enhancement of muscarinic receptor-stimulated accumulation of [3H]CDP-DAG. It is thus possible to manipulate cellular inosito1 as an experimental variable. The results indicate a selective effect of Li' on inositol-deficient tissues. In the case of brain slices, this is a consequence of washing in inositol-free buffer, whereas in the case of cultured cells, it is accomplished by growth on inositolfree media. It appears that much of the variation seen in different experimental preparations for the study of brain Li+ effects can be explained on the basis of differences in inositol content. Adult rat brain inositol content is 3-5 mM (Sherman et al., 1985) , and 60-80% of this is lost in brain slice preparation as reported by Sherman et al. (1 986) , which is confirmed in the present study. SK-N-SH neuroblastoma cells have comparably high inositol levels, but unlike brain slices, retain their inositol even after extensive washing in inositol-free buffer. The ability to concentrate and/or retain inositol in various cell lines has not been studied systematically, although it has been reported that C6 glioma cells maintain a higher intracellular/ extracellular inositol gradient than N 1 E-1 15 neuroblastoma cells (Glanville et al., 1989) . The lowest levels of cellular inositol encountered in this study were in inositol-deprived cells that were also carbachol stimulated. The observation could be taken as support for the existence of low inositol levels in stimulated cells that then become subject to the Li+-mediated slowing of phosphoinositide turnover, as is proposed in the inositol-depletion hypothesis. It is also of interest that even when inositol is not available to SK-N-SH cells, they exhibit relatively normal growth rates. This may indicate the presence of some activity of inositol 3-phosphate synthase. This enzyme, which cyclizes glucose 6-phosphate, is thought to reside primarily in the brain capillary endothelium (Wong et al., 1987) .
The observed Lif-independent, muscannic stimulation of [3H]CDP-DAG formation in neuroblastoma cells grown in standard growth media is interpreted to indicate that the PI synthase of these cells is normally saturated with regard to inositol and is operating near its V,,,. This interpretation would also explain the observed ineffectiveness of added inositol in reversing the [3H]CDP-DAG accumulation. Alternatively, the observed stimulatory effect of the addition of carbachol alone on [3H]CDP-DAG accumulation in cells that had not been depleted of their inositol could indicate the presence of a "low inositol" intracellular compartment together with PI synthase. Such an explanation has been suggested as a result of kinetic studies of CDP-DAG accumulation in sciatic nerve (Zhu and Eichberg, 1990) . This possibility appears unlikely in the present study because coincubation of SK-N-SH cells with I0 mMinosito1 did not block the stimu-
The plateau of [3H]CDP-DAG seen after muscarinic receptor activation in cells cultured in inositolcontaining media is interpreted to indicate the development under these conditions of a steady state in which the rate of synthesis of the liponucleotide approaches its rate of degradation. The subsequent receptor blockade by atropine then leads to reduced PIP, breakdown, and thereby limits the availability of (stearoyl arachidonoyl) DAG for PI resynthesis. When the metabolic fate of CDP-DAG was further investigated in inositol-depleted cells, an increased rate of labeled liponucleotide formation was ob-served, particularly at later incubation times. This increased rate suggests a slowing of PI synthase secondary to a reduction in available inositol. The late increase then likely reflects further depletion of available inositol and arrest of PI synthase activity. Under these conditions, the loss of [3H]CDP-DAG seen upon addition of atropine is indicative of ongoing metabolism of CDP-DAG other than via PI synthase. For example, the liponucleotide could be metabolized to phosphatidate, either by reversal of the CDP-DAG synthase reaction or by pyrophosphorolysis (Murthy and Agranoff, 1982) . Because CDP-DAG may be a limiting substrate in the phosphoinositide cycle, CDP-DAG pyrophosphatase could well serve a regulatory function. Still another possibility, the conversion of CDP-DAG to the phosphatidylglycerolipids appears improbable because these mitochondria1 structural lipids turn over relatively slowly.
It is clear from the present study that varying the cellular inositol concentration can drastically alter the observed biochemical effects of Li' , and further, that the inositol content of cultured cells is more representative of intact rat brain than is that of washed rat brain slices. Because SK-N-SH cells do not survive in millimolar Li+-containing media for long periods of time, we could not explore the possible effects of Li+ that can be elicited only after several days of in vivo exposure. Although we observed no significant inosito1 decrease in cultured cells exposed briefly to Li+, it remains possible that exposure of the intact brain to a combination of chronic Li+ and a sustained excess of phosphoinositide-linked ligands (perhaps in specific brain regions) leads to the inositol depletion that has been hypothesized to mediate the psychotherapeutic effect of Li+. The present study nevertheless underscores potential hazards in simple extrapolation of in vitro results, on the one hand, and oversimplification of mechanism, on the other, to explain the in vivo effects of Li+.
